Cristina Popescu

Dr. Cristina Popescu

Department of Oncologic Dermatology—“Elias” Emergency University Hospital, “Carol Davila” University of Medicine and Pharmacy, 020021 Bucharest, Romania
orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in BioMed Research International
Verified
Journal Article
Open access
PDF file
DTDana Thompson
Dana Thompson
MBMadalina Gabriela Barbu
Madalina Gabriela Barbu
Cristina PopescuCristina Popescu
Cristina Popescu
Liliana Gabriela PopaLiliana Gabriela Popa
Liliana Gabriela Popa
Mara MihaiMara Mihai
Mara Mihai
Marius Nicolae PopescuMarius Nicolae Popescu
Marius Nicolae Popescu
The COVID‐19 pandemic had a great negative impact on nursing homes, with massive outbreaks being reported in care facilities all over the world, affecting not only the residents but also the care workers and visitors. Due to their advanced age and numerous underlying diseases, the inhabitants of long‐term care facilities represent a vulnerable population that should benefit from additional protective measures against contamination. Recently, multiple countries such as France, Spain, Belgium, Canada, and the United States of America reported that an important fraction from the total number of deaths due to the SARS‐CoV‐2 infection emerged from nursing homes. The scope of this paper was to present the latest data regarding the COVID‐19 spread in care homes worldwide, identifying causes and possible solutions that would limit the outbreaks in this overlooked category of population. It is the authors’ hope that raising awareness on this matter would encourage more studies to be conducted, considering the fact that there is little information available on the impact of the SARS‐CoV‐2 pandemic on nursing homes. Establishing national databases that would register all nursing home residents and their health status would be of great help in the future not only for managing the ongoing pandemic but also for assessing the level of care that is needed in this particularly fragile setting.

2 April 2020 in Cureus
Verified
Journal Article
Open access
PDF file
Cristina PopescuCristina Popescu
Cristina Popescu
Mara MihaiMara Mihai
Mara Mihai
Liliana Gabriela PopaLiliana Gabriela Popa
Liliana Gabriela Popa
LCLuiza Cima
Luiza Cima
MPMarius N. Popescu
Marius N. Popescu
Coronavirus disease 2019 (COVID-19) continues to spread globally, outpacing the capacity and resources of health systems worldwide. A therapeutic vaccine is not yet on the rise, and preventive measures are the current approach to restraint the transmission of cases. As the virus is highly contagious via respiratory route (droplets from infected persons, widely spread by coughing or sneezing) and via contact with contaminated surfaces, community transmission and spread can be decreased through the practice of regular and diligent hand hygiene. Frequent hand washing implies a prolonged exposure to water and other chemical or physical agents and may induce several pathophysiologic changes, such as epidermal barrier disruption, impairment of keratinocytes, the subsequent release of proinflammatory cytokines, activation of the skin immune system, and delayed-type hypersensitivity reactions. Adverse dermatologic effects, such as excessive skin dryness or even contact dermatitis (particularly the irritant subtype and, to a lesser extent, the allergic subtype), can occur, especially in individuals with a history of atopic dermatitis. These skin conditions are perfectly manageable, and applying a moisturizer immediately after washing hands or after using a portable hand sanitizer is the cornerstone in preventing the development of eczematous changes in the hands. In the current global context, the potential occurrence of these dermatological adverse events should in no way cause people to deviate from strict hand hygiene rules.

28 May 2023 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
AMAdrian Miron
Adrian Miron
CGCalin Giurcaneanu
Calin Giurcaneanu
Mara MihaiMara Mihai
Mara Mihai
Cristina PopescuCristina Popescu
Cristina Popescu
VVVlad Mihai Voiculescu
Vlad Mihai Voiculescu
Liliana Gabriela PopaLiliana Gabriela Popa
Liliana Gabriela Popa
Chronic wounds encompass a myriad of lesions, including venous and arterial leg ulcers, diabetic foot ulcers (DFUs), pressure ulcers, non-healing surgical wounds and others. Despite the etiological differences, chronic wounds share several features at a molecular level. The wound bed is a convenient environment for microbial adherence, colonization and infection, with the initiation of a complex host–microbiome interplay. Chronic wound infections with mono- or poly-microbial biofilms are frequent and their management is challenging due to tolerance and resistance to antimicrobial therapy (systemic antibiotic or antifungal therapy or antiseptic topicals) and to the host’s immune defense mechanisms. The ideal dressing should maintain moisture, allow water and gas permeability, absorb wound exudates, protect against bacteria and other infectious agents, be biocompatible, be non-allergenic, be non-toxic and biodegradable, be easy to use and remove and, last but not least, it should be cost-efficient. Although many wound dressings possess intrinsic antimicrobial properties acting as a barrier to pathogen invasion, adding anti-infectious targeted agents to the wound dressing may increase their efficiency. Antimicrobial biomaterials may represent a potential substitute for systemic treatment of chronic wound infections. In this review, we aim to describe the available types of antimicrobial biomaterials for chronic wound care and discuss the host response and the spectrum of pathophysiologic changes resulting from the contact between biomaterials and host tissues.

23 January 2020 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
Cristina PopescuCristina Popescu
Cristina Popescu
CGCalin Giurcaneanu
Calin Giurcaneanu
Alexandru Mihai GrumezescuAlexandru Mihai Grumezescu
Alexandru Mihai Grumezescu
Alina Maria HolbanAlina Maria Holban
Alina Maria Holban
Liliana Gabriela PopaLiliana Gabriela Popa
Liliana Gabriela Popa
MMMara Mădălina Mihai
Mara Mădălina Mihai
Melanoma is one of the most aggressive forms of skin cancer, with limited therapeutic options. Since its incidence has been rapidly rising in recent years, the study of new targeted therapeutic strategies has increased. The implication of nanoscience in the development of alternative targeted therapies for melanoma has multiple benefits and could significantly improve the outcome of melanoma patients. In this paper, we review the most recent progress in the field of targeted therapies, emphasizing the impact of nanoscale materials on the targeting and controlled release of anti-tumor drugs. The applications of nanomedicine in the management of melanoma are extensive and refer to sentinel lymph node mapping, chemotherapy, and RNA interference; each of these applications harboring the potential to develop efficient and personalized diagnostic techniques and therapies. Further research, especially in clinical trials, is needed to establish whether fighting melanoma on the nanoscale level represents the key to reaching a critical inflection point in mankind’s battle with metastatic melanoma.

1 July 2022 in European Journal of Physical and Rehabilitation Medicine
Verified
Journal Article
Closed access
EMEmanuela E. Mihai
Emanuela E. Mihai
Marius Nicolae PopescuMarius Nicolae Popescu
Marius Nicolae Popescu
AIAlina N. Iliescu
Alina N. Iliescu
MBMihai Berteanu
Mihai Berteanu
Article: A systematic review on extracorporeal shock wave therapy and botulinum toxin for spasticity treatment: a comparison on efficacy - European Journal of Physical and Rehabilitation Medicine 2022 Apr 12 - Minerva Medica - Journals

25 January 2023 in Metabolites
Verified
Journal Article
Open access
PDF file
AUAndreea Bianca Uzun
Andreea Bianca Uzun
MIMadalina Gabriela Iliescu
Madalina Gabriela Iliescu
LSLiliana Elena Stanciu
Liliana Elena Stanciu
EIElena Valentina Ionescu
Elena Valentina Ionescu
Rodica UngurRodica Ungur
Rodica Ungur
DTDoina Ecaterina Tofolean
Doina Ecaterina Tofolean
Intermittent oxygen therapy (IHT), initially used in the hypoxic administration variant, has been shown to be effective in various pathologies studied, from cardiopulmonary to vascular and metabolic pathologies and more. IHT used to prevent and treat various diseases has thus gained more and more attention as the years have passed. The mechanisms underlying the beneficial effects have been investigated at multiple biological levels, from systemic physiological reactions to genomic regulation. In the last decade, a new method of intermittent oxygen therapy has been developed that combines hypoxic and hyperoxic periods. They can be applied both at rest and during physical exercise, hence the specific indications in sports medicine. It has been hypothesized that replacing normoxia with moderate hyperoxia may increase the adaptive response to the intermittent hypoxic stimulus by upregulating reactive oxygen species and hypoxia-inducible genes. This systematic literature review is based on the “Preferred Reporting Items for Systematic Reviews and Meta-Analysis”—“PRISMA”—methodology, the widely internationally accepted method.